Prosight Management, LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001617201

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallHealth TiltHigh Turnover how tags are computed

Q2 2024 · 46 positions · Total reported value $334.57M · Top-10 concentration 58.8% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 75.6% · 9 new · 12 cut · 13 exited

Active Share (vs S&P 500): 99.8% · vs QQQ: 99.9% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -1.1% · vs SPY -3.2% · Prev Value $580.35M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -6.1% · vs SPY -8.3% · Latest Value $515.48M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q2 2024 13F filing, Prosight Management, LP disclosed 46 equity positions with a combined reported value of $334.57M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 58.8% of reported value. HoldingsHub classifies the profile as Small / Health Tilt / High Turnover.

The largest disclosed positions as of Q2 2024 were LKFT ($33.45M), ADCT ($30.24M), ROIV ($21.14M). By sector, the heaviest allocations are Health Care 82.7%, Consumer Discretionary 3.2%. Versus the prior quarter, allocation shifted toward Other (+3.9pp), Consumer Staples (+0.7pp) and away from Health Care (-4.4pp).

Versus the prior quarter, Prosight Management, LP opened 9 new positions, trimmed 12 and fully exited 13, a turnover rate of 75.6% of positions. The portfolio's overlap with the prior quarter was 61% of names.

The largest new positions opened in Q2 2024 were SNDX ($11.32M), SDGR ($7.14M), ACCD ($5.33M).

Of the 13 positions fully exited versus the prior quarter, the largest were GH ($9.70M), PFE ($5.97M), MRVI ($5.20M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2024)

  • SNDX SYNDAX PHARMACEUTICALS INC · $11.32M
  • SDGR SCHRODINGER INC · $7.14M
  • ACCD ACCOLADE INC · $5.33M
  • CVS CVS HEALTH CORP · $2.36M
  • VINC VINCERX PHARMA INC · $2.02M
  • INSP INSPIRE MED SYS INC · $1.87M
  • FNA PARAGON 28 INC · $1.79M
  • ADUS ADDUS HOMECARE CORP · $1.45M

Fully Exited (vs previous quarter)

  • GH GUARDANT HEALTH INC · prev qtr: $9.70M
  • PFE PFIZER INC · prev qtr: $5.97M
  • MRVI MARAVAI LIFESCIENCES HLDGS I · prev qtr: $5.20M
  • CRBP CORBUS PHARMACEUTICALS HLDGS · prev qtr: $3.95M · history
  • BBSI BARRETT BUSINESS SVCS INC · prev qtr: $3.04M
  • PCRX PACIRA BIOSCIENCES INC · prev qtr: $2.76M
  • NUVB NUVATION BIO INC · prev qtr: $910.00K
  • AGIO AGIOS PHARMACEUTICALS INC · prev qtr: $731.00K

Insider Transactions (Form 4)

Latest Prosight Management, LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Prosight Management, LP is an SEC-registered 13F filer based in Dallas, TX, United States. As of Q2 2026 it reported 36 US equity positions with a combined value of $580.35M. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: DALLAS, TX, United States
  • SEC registration: 801-108047 (status: Approved), registered 2016-07-01
  • Regulatory AUM (Form ADV): $1.04B as of 2026-03-30
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 2 private funds, of which 2 hedge funds
  • Website: prosightcapital.com

Portfolio Structure

  • 36 positions · $580.35M reported value (Q2 2026)
  • Top 10 holdings = 70.7% of reported value
  • Largest position: LKFT (LAKEFRONT BIOTHERAPEUTICS NV) at 10.6%
  • Average position size: $16.12M

Sector Tilt

  • Health Care 83.6%
  • Information Technology 3.2%
  • (classified holdings cover 87% of value)

Quarterly Activity

  • Q2 2026: 5 new, 16 added, 15 reduced, 15 exited

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 82.7%
Other 13.2%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 1.35M $33.45M 10.00%
10.00%
Add
2 9.57M $30.24M 9.04%
9.04%
Add
3 2.00M $21.14M 6.32%
6.32%
Add
4 800.00K $20.26M 6.06%
6.06%
Add
5 170.00K $18.45M 5.51%
5.51%
Add
6 4.35M $18.32M 5.48%
5.48%
Add
7 4.67M $18.03M 5.39%
5.39%
Add
8 629.90K $12.97M 3.88%
3.88%
Reduce
9 230.00K $12.46M 3.73%
3.73%
Reduce
10 551.54K $11.32M 3.38%
3.38%
New
11 314.80K $10.76M 3.22%
3.22%
Reduce
12 492.34K $10.54M 3.15%
3.15%
Add
13 1.18M $10.04M 3.00%
3.00%
Add
14 325.00K $8.58M 2.56%
2.56%
Add
15 369.26K $7.14M 2.13%
2.13%
New
16 2.35M $6.96M 2.08%
2.08%
Add
17 275.00K $6.63M 1.98%
1.98%
Add
18 2.75M $6.49M 1.94%
1.94%
Reduce
19 115.00K $6.10M 1.82%
1.82%
Add
20 286.93K $5.92M 1.77%
1.77%
Add
21 200.22K $5.76M 1.72%
1.72%
Reduce
22 205.00K $5.68M 1.70%
1.70%
Add
23 49.32K $5.59M 1.67%
1.67%
Add
24 1.49M $5.33M 1.59%
1.59%
New
25 500.00K $4.21M 1.26%
1.26%
Reduce
26 27.00K $3.72M 1.11%
1.11%
Reduce
27 385.00K $2.51M 0.75%
0.75%
Reduce
28 398.70K $2.46M 0.74%
0.74%
Reduce
29 40.00K $2.36M 0.71%
0.71%
New
30 30.00K $2.36M 0.71%
0.71%
Reduce
31 2.49M $2.02M 0.60%
0.60%
New
32 14.00K $1.87M 0.56%
0.56%
New
33 261.40K $1.79M 0.53%
0.53%
New
34 9.37K $1.73M 0.52%
0.52%
Reduce
35 96.06K $1.67M 0.50%
0.50%
Add
36 475.46K $1.49M 0.45%
0.45%
Add
37 12.50K $1.45M 0.43%
0.43%
New
38 67.46K $1.11M 0.33%
0.33%
New
39 59.54K $1.03M 0.31%
0.31%
Reduce
40 49.02K $953.46K 0.28%
0.28%
Add
41 1.07M $826.89K 0.25%
0.25%
Add
42 65.00K $786.50K 0.23%
0.23%
New
43 265.00K $734.05K 0.22%
0.22%
New
44 550.00K $704.00K 0.21%
0.21%
New
45 124.38K $559.70K 0.17%
0.17%
Add
46 56.08K $33.65K 0.01%
0.01%
Reduce

FAQ

What did Prosight Management, LP buy in 2024-Q2?

In its 2024-Q2 13F filing, Prosight Management, LP reported 46 equity positions worth $334.57M in aggregate; its largest disclosed positions were LKFT ($33.45M), ADCT ($30.24M), ROIV ($21.14M).

How large is Prosight Management, LP's portfolio?

Prosight Management, LP reported $334.57M of long equity holdings across 46 positions as of 2024-Q2. Top-10 holdings account for 58.8% of reported value.

What is Prosight Management, LP's investment style?

HoldingsHub classifies the portfolio as Small / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/prosight-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →